{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:20:13Z","timestamp":1784841613082,"version":"3.55.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11912-018-0721-y","type":"journal-article","created":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T07:29:05Z","timestamp":1541834945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes"],"prefix":"10.1007","volume":"20","author":[{"given":"Ronnyson Susano","family":"Grativvol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner Cid Palmeira","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Henrique Martins","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Nitrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus Mistieri","family":"Simabukuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,10]]},"reference":[{"issue":"2 Neuro-oncolog","key":"721_CR1","first-page":"452","volume":"21","author":"E Lancaster","year":"2015","unstructured":"Lancaster E. Paraneoplastic disorders. Contin Minneap Minn. 2015;21(2 Neuro-oncology):452\u201375.","journal-title":"Contin Minneap Minn"},{"issue":"16","key":"721_CR2","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMra023009","volume":"349","author":"RB Darnell","year":"2003","unstructured":"Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543\u201354.","journal-title":"N Engl J Med"},{"issue":"7","key":"721_CR3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","volume":"13","author":"CA Vedeler","year":"2006","unstructured":"Vedeler CA, Antoine JC, Giometto B, Graus F, Grisold W, Hart IK, et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol. 2006;13(7):682\u201390.","journal-title":"Eur J Neurol"},{"issue":"3","key":"721_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1212\/CPJ.0b013e31826af23e","volume":"2","author":"MR Rosenfeld","year":"2012","unstructured":"Rosenfeld MR, Titulaer MJ, Dalmau J. Paraneoplastic syndromes and autoimmune encephalitis five new things. Neurol Clin Pract. 2012;2(3):215\u201323.","journal-title":"Neurol Clin Pract"},{"key":"721_CR5","volume-title":"The remote effects of cancer on the nervous system","author":"WR Brain","year":"1965","unstructured":"Brain WR, Norris FH. The remote effects of cancer on the nervous system. New York: Grune and Stratton; 1965."},{"issue":"5","key":"721_CR6","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1093\/brain\/aws064","volume":"135","author":"J Dalmau","year":"2012","unstructured":"Dalmau J, Graus F. Paraneoplastic syndromes: from remote to clear and present knowledge. Brain. 2012;135(5):1650\u2013553.","journal-title":"Brain"},{"issue":"3","key":"721_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/brain\/88.3.529","volume":"88","author":"PC Wilkinson","year":"1965","unstructured":"Wilkinson PC, Zeromski J. Immunofluorescent detection of antibodies against Neurones in sensory carcinomatous neuropathy. Brain. 1965;88(3):529\u201338.","journal-title":"Brain"},{"issue":"9","key":"721_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/archneur.1976.00500090066014","volume":"33","author":"JL Trotter","year":"1976","unstructured":"Trotter JL, Hendin BA, Osterland CK. Cerebellar degeneration with Hodgkin disease: an immunological study. Arch Neurol. 1976;33(9):660\u20131.","journal-title":"Arch Neurol"},{"issue":"3","key":"721_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/91.3.481","volume":"91","author":"JA Corsellis","year":"1968","unstructured":"Corsellis JA, Goldberg GJ, Norton AR. \u201cLimbic encephalitis\u201d and its association with carcinoma. Brain J Neurol. 1968;91(3):481\u201396.","journal-title":"Brain J Neurol"},{"issue":"11","key":"721_CR10","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1212\/WNL.41.11.1757","volume":"41","author":"J Dalmau","year":"1991","unstructured":"Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis\/sensory neuronopathy. Neurology. 1991;41(11):1757\u201364.","journal-title":"Neurology"},{"issue":"1\u20132","key":"721_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0165-5728(96)00153-1","volume":"71","author":"P Sillevis Smitt","year":"1996","unstructured":"Sillevis Smitt P, Manley G, Dalmau J, Posner J. The HuD paraneoplastic protein shares immunogenic regions between PEM\/PSN patients and several strains and species of experimental animals. J Neuroimmunol. 1996;71(1\u20132):199\u2013206.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"721_CR12","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1212\/WNL.51.4.1146","volume":"51","author":"R Voltz","year":"1998","unstructured":"Voltz R, Dalmau J, Posner JB, Rosenfeld MR. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology. 1998;51(4):1146\u201350.","journal-title":"Neurology"},{"issue":"8","key":"721_CR13","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1093\/brain\/awh205","volume":"127","author":"H Pellkofer","year":"2004","unstructured":"Pellkofer H, Schubart AS, H\u00f6ftberger R, Schutze N, Pagany M, Sch\u00fcller M, et al. Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. Brain. 2004;127(8):1822\u201330.","journal-title":"Brain"},{"issue":"1","key":"721_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, T\u00fcz\u00fcn E, Wu H, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25\u201336.","journal-title":"Ann Neurol"},{"issue":"4","key":"721_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.21589","volume":"65","author":"M Lai","year":"2009","unstructured":"Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65(4):424\u201334.","journal-title":"Ann Neurol"},{"issue":"1","key":"721_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, et al. Antibodies to the GABA B receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9(1):67\u201376.","journal-title":"Lancet Neurol"},{"issue":"8","key":"721_CR17","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","volume":"9","author":"M Lai","year":"2010","unstructured":"Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9(8):776\u201385.","journal-title":"Lancet Neurol"},{"issue":"9","key":"721_CR18","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain. 2010;133(9):2734\u201348.","journal-title":"Brain"},{"issue":"2","key":"721_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.22297","volume":"69","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Huijbers MGM, Bar V, Boronat A, Wong A, Martinez-Hernandez E, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol. 2011;69(2):303\u201311.","journal-title":"Ann Neurol"},{"key":"721_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/nyas.12553","volume":"1338","author":"F Leypoldt","year":"2015","unstructured":"\u2022\u2022 Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci. 2015;1338:94\u2013114. Outstanding review of the autoimmune encephalitis syndromes, clinical features, and immune associations","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"721_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ana.20614","volume":"58","author":"R Vitaliani","year":"2005","unstructured":"Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;58(4):594\u2013604.","journal-title":"Ann Neurol"},{"issue":"6","key":"721_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13(6):575\u201386.","journal-title":"Lancet Neurol"},{"issue":"5","key":"721_CR23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/ana.21807","volume":"66","author":"RC Dale","year":"2009","unstructured":"Dale RC, Irani SR, Brilot F, Pillai S, Webster R, Gill D, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol. 2009;66(5):704\u20139.","journal-title":"Ann Neurol"},{"issue":"7","key":"721_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","volume":"8","author":"E Lancaster","year":"2012","unstructured":"Lancaster E, Dalmau J. Neuronal autoantigens\u2014pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 2012;8(7):380\u201390.","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"721_CR25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","volume":"10","author":"J Granerod","year":"2010","unstructured":"Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835\u201344.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"721_CR26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/cid\/cir1038","volume":"54","author":"MS Gable","year":"2012","unstructured":"Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012;54(7):899\u2013904.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"721_CR27","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3201\/eid1909.130064","volume":"19","author":"J Granerod","year":"2013","unstructured":"Granerod J, Cousens S, Davies NWS, Crowcroft NS, Sara L. Thomas. New estimates of incidence of encephalitis in England. Emerg Infect Dis. 2013;19(9):1455\u201362.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"721_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1212\/WNL.0000000000000086","volume":"82","author":"NM Vora","year":"2014","unstructured":"Vora NM, Holman RC, Mehal JM, Steiner CA, Blanton J, Sejvar J. Burden of encephalitis-associated hospitalizations in the United States, 1998\u20132010. Neurology. 2014;82(5):443\u201351.","journal-title":"Neurology"},{"issue":"8","key":"721_CR29","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"721_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","volume":"18","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Soffietti R, Dalmau J, Gilhus NE, Giometto B, Graus F, et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force: screening for tumours in PNS. Eur J Neurol. 2011;18(1):19\u201327.","journal-title":"Eur J Neurol"},{"key":"721_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1172-2-22","volume":"2","author":"J Honnorat","year":"2007","unstructured":"Honnorat J, Antoine J-C. Paraneoplastic neurological syndromes. Orphanet J Rare Dis. 2007;2:22.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"721_CR32","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1212\/NXI.0000000000000073","volume":"2","author":"Mateus Mistieri Simabukuro","year":"2015","unstructured":"Simabukuro MM, Petit-Pedrol M, Castro LH, Nitrini R, Lucato L, Zambon AA, et al. GABAA receptor and LGI1 antibody encephalitis in a patient with thymoma. Neurol-Neuroimmunol Neuroinflammation. 2015;2(2):e73.","journal-title":"Neurology - Neuroimmunology Neuroinflammation"},{"issue":"11","key":"721_CR33","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","volume":"79","author":"SE Schmitt","year":"2012","unstructured":"Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012;79(11):1094\u2013100.","journal-title":"Neurology"},{"issue":"3","key":"721_CR34","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/archneurol.2009.341","volume":"67","author":"B Giometto","year":"2010","unstructured":"Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol. 2010;67(3):330\u20135.","journal-title":"Arch Neurol"},{"issue":"6","key":"721_CR35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.23550","volume":"71","author":"E Graaff de","year":"2012","unstructured":"de Graaff E, Maat P, Hulsenboom E, van den Berg R, van den Bent M, Demmers J, et al. Identification of delta\/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2012;71(6):815\u201324.","journal-title":"Ann Neurol"},{"issue":"2, Neuro-oncolo","key":"721_CR36","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/01.CON.0000413664.42798.aa","volume":"18","author":"MR Rosenfeld","year":"2012","unstructured":"Rosenfeld MR, Dalmau JO. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Contin Lifelong Learn Neurol. 2012;18(2, Neuro-oncology):366\u201383.","journal-title":"Contin Lifelong Learn Neurol"},{"issue":"4","key":"721_CR37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"\u2022\u2022 Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404. A position letter based on literature review and gathered the experience of a team of experts with the aims of developing a practical, syndrome-based diagnostic approach to autoimmune encephalitis and providing guidelines to navigate through the differential diagnosis","journal-title":"Lancet Neurol"},{"issue":"2","key":"721_CR38","doi-asserted-by":"publisher","first-page":"1672177","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13(2):1672177.","journal-title":"Lancet Neurol"},{"issue":"8","key":"721_CR39","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/brain\/awh203","volume":"127","author":"J. Dalmau","year":"2004","unstructured":"Dalmau J. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004 Jun 16;127(8):1831\u20131844.","journal-title":"Brain"},{"issue":"2","key":"721_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","volume":"71","author":"J Dalmau","year":"1992","unstructured":"Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis\/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore). 1992;71(2):59\u201372.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"721_CR41","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","volume":"124","author":"F. Graus","year":"2001","unstructured":"Graus F. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001 Jun 1;124(6):1138\u20131348.","journal-title":"Brain"},{"issue":"4","key":"721_CR42","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/jnnp.2008.158246","volume":"80","author":"A Saiz","year":"2008","unstructured":"Saiz A, Bruna J, Stourac P, Vigliani MC, Giometto B, Grisold W, et al. Anti-Hu-associated brainstem encephalitis. J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):404\u2013407.","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"4","key":"721_CR43","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","volume":"80","author":"J Honnorat","year":"2008","unstructured":"Honnorat J, Cartalat-Carel S, Ricard D, Camdessanche JP, Carpentier AF, Rogemond V, et al. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2\/CRMP5 antibodies. J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):412\u2013416.","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"8","key":"721_CR44","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/brain\/120.8.1279","volume":"120","author":"W. Mason","year":"1997","unstructured":"Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain. 1997 Aug 1;120(8):1279\u20131300.","journal-title":"Brain"},{"issue":"1-2","key":"721_CR45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jneuroim.2005.04.001","volume":"164","author":"Paul W. Wirtz","year":"2005","unstructured":"Wirtz PW, Lang B, Graus F, van den Maagdenberg AMJM, Saiz A, Gans PA de K, et al. P\/Q-type calcium channel antibodies, Lambert\u2013Eaton myasthenic syndrome and survival in small cell lung cancer. J Neuroimmunol. 2005 Jul 1;164(1):161\u2013165.","journal-title":"Journal of Neuroimmunology"},{"issue":"5","key":"721_CR46","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1212\/WNL.59.5.764","volume":"59","author":"F. Graus","year":"2002","unstructured":"Graus F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A. P\/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology. 2002 Sep 10;59(5):764\u2013766.","journal-title":"Neurology"},{"key":"721_CR47","doi-asserted-by":"crossref","unstructured":"Sabater L, H\u00f6ftberger R, Boronat A, Saiz A, Dalmau J, Graus F. Antibody Repertoire in Paraneoplastic Cerebellar Degeneration and Small Cell Lung Cancer. PLOS ONE. 2013 Mar 25;8(3):e60438.","DOI":"10.1371\/journal.pone.0060438"},{"issue":"21","key":"721_CR48","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1182\/blood-2014-03-537506","volume":"123","author":"F. Graus","year":"2014","unstructured":"Graus F, Ari\u00f1o H, Dalmau J. Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas. Blood. 2014;123:3230\u20133238.","journal-title":"Blood"},{"issue":"1","key":"721_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM200001063420104","volume":"342","author":"Peter Sillevis Smitt","year":"2000","unstructured":"Smitt PS, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, et al. Paraneoplastic Cerebellar Ataxia Due to Autoantibodies against a Glutamate Receptor. N Engl J Med. 2000 Jan 6; 342(1):21\u201327.","journal-title":"New England Journal of Medicine"},{"key":"721_CR50","doi-asserted-by":"crossref","unstructured":"Marignier R, Chenevier F, Rogemond V, et al. Metabotropic glutamate receptor type 1 autoantibody\u2013associated cerebellitis: A primary autoimmune disease? Arch Neurol. 2010 May 1;67(5):627\u2013630.","DOI":"10.1001\/archneurol.2010.51"},{"issue":"1-2","key":"721_CR51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jneuroim.2013.07.015","volume":"263","author":"Raffaele Iorio","year":"2013","unstructured":"Iorio R, Damato V, Mirabella M, Vita MG, Hulsenboom E, Plantone D, et al. Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma. J Neuroimmunol. 2013 Oct 15;263(1\u20132):155\u2013158.","journal-title":"Journal of Neuroimmunology"},{"issue":"11","key":"721_CR52","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1212\/WNL.0000000000002476","volume":"86","author":"A. Sebastian Lopez-Chiriboga","year":"2016","unstructured":"\u2022 Lopez-Chiriboga AS, Komorowski L, K\u00fcmpfel T, Probst C, Hinson SR, Pittock SJ, et al. Metabotropic glutamate receptor type 1 autoimmunity Clinical features and treatment outcomes. Neurology. 2016 Mar 15;86(11):1009\u20131013. It retrospectively describes the clinical associations of immunoglobulin G (IgG) targeting metabotropic glutamate receptor 1 (mGluR1-IgG). The largest series of patients with mGLUr1 ataxia.","journal-title":"Neurology"},{"issue":"7","key":"721_CR53","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","volume":"123","author":"S. H. Gultekin","year":"2000","unstructured":"Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000 Jul 1;123(7):1481\u20131494.","journal-title":"Brain"},{"key":"721_CR54","doi-asserted-by":"crossref","unstructured":"\u2022 van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MAAM, et al. Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up. Neurology. 2016 Oct 4;87(14):1449\u20131456. A nationwide study; a detailed description of the clinical features and long-term outcome of a LGI1 encephalitis.","DOI":"10.1212\/WNL.0000000000003173"},{"issue":"8","key":"721_CR55","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","volume":"87","author":"Helena Ari\u00f1o","year":"2016","unstructured":"\u2022 Ari\u00f1o H, Armangu\u00e9 T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M, et al. Anti-LGI1\u2013associated cognitive impairment Presentation and long-term outcome. Neurology. 2016 Aug 23;87(8):759\u2013765. This paper determines the clinical presentation, long-term outcome, and LGI1 encephalitis evolution.","journal-title":"Neurology"},{"key":"721_CR56","doi-asserted-by":"crossref","unstructured":"van Sonderen A, Ari\u00f1o H, Petit-Pedrol M, Leypoldt F, K\u00f6rtv\u00e9lyessy P, Wandinger K-P, et al. The clinical spectrum of Caspr2 antibody-associated disease. Neurology. 2016 Aug 2;87(5):521\u2013528.","DOI":"10.1212\/WNL.0000000000002917"},{"issue":"17","key":"721_CR57","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","volume":"81","author":"R. Hoftberger","year":"2013","unstructured":"H\u00f6ftberger R, Titulaer MJ, Sabater L, Dome B, R\u00f3zs\u00e1s A, Hegedus B, et al. Encephalitis and GABAB receptor antibodies Novel findings in a new case series of 20 patients. Neurology. 2013;81(17):1500\u20131506.","journal-title":"Neurology"},{"issue":"24","key":"721_CR58","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","volume":"84","author":"R. Hoftberger","year":"2015","unstructured":"H\u00f6ftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, et al. Encephalitis and AMPA receptor antibodies Novel findings in a case series of 22 patients. Neurology. 2015 Jun 16;84(24):2403\u20132412.","journal-title":"Neurology"},{"issue":"1","key":"721_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/mds.870100106","volume":"10","author":"John N. Caviness","year":"1995","unstructured":"Caviness JN, Forsyth PA, Layton DD, McPhee TJ. The movement disorder of adult opsoclonus. Mov Disord Off J Mov Disord Soc. 1995 Jan;10(1):22\u201327.","journal-title":"Movement Disorders"},{"issue":"12","key":"721_CR60","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1001\/archneurol.2012.1173","volume":"69","author":"James P. Klaas","year":"2012","unstructured":"Klaas JP, Ahlskog J, Pittock SJ, et al. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012 Dec 1;69(12):1598\u20131607.","journal-title":"Archives of Neurology"},{"issue":"3","key":"721_CR61","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1136\/jnnp.25.3.271","volume":"25","author":"M. Kinsbourne","year":"1962","unstructured":"Kinsbourne M. Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry. 1962 Aug;25(3):271\u2013276.","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"3","key":"721_CR62","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/practneurol-2011-000017","volume":"11","author":"J. K. Sahu","year":"2011","unstructured":"Sahu JK, Prasad K. The opsoclonus\u2013myoclonus syndrome. Pract Neurol. 2011 Jun 1;11(3):160\u2013166.","journal-title":"Practical Neurology"},{"issue":"4","key":"721_CR63","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/jamaneurol.2015.4607","volume":"73","author":"Tha\u00eds Armangu\u00e9","year":"2016","unstructured":"\u2022 Armangu\u00e9 T, Sabater L, Torres-Vega E, Mart\u00ednez-Hern\u00e1ndez E, Ari\u00f1o H, Petit-Pedrol M, et al. Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies. JAMA Neurol. 2016 Apr;73(4):417\u2013424. Report of the clinical and immunological features of idiopathic OMS (I-OMS) andparaneoplastic OMS (P-OMS), the occurrence of antibodies to cell surface antigens, and the discovery of a novel cell surface epitope.","journal-title":"JAMA Neurology"},{"key":"721_CR64","doi-asserted-by":"crossref","unstructured":"Bataller L, Graus F, Saiz A, Vilchez JJ, Spanish Opsoclonus-Myoclonus Study Group. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain J Neurol. 2001 Feb;124(Pt 2):437\u2013443.","DOI":"10.1093\/brain\/124.2.437"},{"issue":"2","key":"721_CR65","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11940-009-0013-9","volume":"11","author":"Marinos C. Dalakas","year":"2009","unstructured":"Dalakas MC. Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Curr Treat Options Neurol. 2009;11(2):102\u2013110.","journal-title":"Current Treatment Options in Neurology"},{"issue":"10","key":"721_CR66","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/brain\/awn183","volume":"131","author":"Albert Saiz","year":"2008","unstructured":"Saiz A, Blanco Y, Sabater L, Gonz\u00e1lez F, Bataller L, Casamitjana R, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008 Oct 1;131(10):2553\u20132263.","journal-title":"Brain"},{"issue":"24","key":"721_CR67","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1212\/01.wnl.0000327342.58936.e0","volume":"71","author":"B. B. Murinson","year":"2008","unstructured":"Murinson BB, Guarnaccia JB. Stiff-person syndrome with amphiphysin antibodies Distinctive features of a rare disease. Neurology. 2008;71(24):1955\u20131958.","journal-title":"Neurology"},{"issue":"1","key":"721_CR68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/brain\/99.1.27","volume":"99","author":"A. M. WHITELEY","year":"1976","unstructured":"Whiteley AM, Swash M, Urich H. Progressive encephalomyelitis with rigidity. Brain J Neurol. 1976 Mar;99(1):27\u201342.","journal-title":"Brain"},{"key":"721_CR69","doi-asserted-by":"crossref","unstructured":"Carvajal-Gonz\u00e1lez A, Leite MI, Waters P, Woodhall M, Coutinho E, Balint B, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain. 2014 Aug","DOI":"10.1093\/brain\/awu142"},{"issue":"1","key":"721_CR70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"Josep Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011 Jan;10(1):63\u201374.","journal-title":"The Lancet Neurology"},{"issue":"11","key":"721_CR71","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","volume":"79","author":"S. E. Schmitt","year":"2012","unstructured":"Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush A unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012;79(11):1094\u20131100.","journal-title":"Neurology"},{"issue":"3","key":"721_CR72","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","volume":"13","author":"M Petit-Pedrol","year":"2014","unstructured":"Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13(3):276\u201386.","journal-title":"Lancet Neurol"},{"key":"721_CR73","doi-asserted-by":"crossref","unstructured":"\u2022 Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort . Lancet Neurol. 2013;12(2):157\u201365. The largest cohort of patients. It assesses the presentation of the disease, the spectrum of symptoms, immunotherapies used, timing of improvement, and long-term outcome.","DOI":"10.1016\/S1474-4422(12)70310-1"},{"issue":"18","key":"721_CR74","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Martinez-Hernandez E, Titulaer MJ, Boulos M, Weaver S, Antoine J-C, et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology. 2011;77(18):1698\u201316701.","journal-title":"Neurology"},{"issue":"12","key":"721_CR75","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/01.wnl.0000252379.81933.80","volume":"68","author":"R. M. Mathew","year":"2006","unstructured":"Mathew RM, Vandenberghe R, Garcia-Merino A, Yamamoto T, Landolfi JC, Rosenfeld MR, et al. Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology. 2007 Mar 20;68(12):900\u2013905.","journal-title":"Neurology"},{"key":"721_CR76","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Dalmau J, Graus F. Antibody-Mediated Encephalitis. Ropper AH, editor. N Engl J Med. 2018 Mar;378(9):840\u2013851. Outstanding review of the autoimmune encephalitis syndromes","DOI":"10.1056\/NEJMra1708712"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-018-0721-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-018-0721-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-018-0721-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T00:19:37Z","timestamp":1573345177000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-018-0721-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1007\/s11912-018-0721-y","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"10 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Ronnyson Susano Grativvol declares that he has no conflict of interest.Wagner Cid Palmeira Cavalcante declares that he has no conflict of interest.Luiz Henrique Martins Castro declares that he has no conflict of interest.Ricardo Nitrini has received research funding from FAPESP, has served on advisory boards for Janssen-Cilag and Brazilian Nutricia, has received travel funding and reimbursement from Novartis, serves as an editor for <i>Dementia & Neuropsychologia<\/i>, serves on the editorial board for <i>Alzheimer\u2019s Disease & Associated Disorders<\/i> and <i>International Journal of Alzheimer\u2019s Disease<\/i>, and has served as a guest speaker for Novartis and Danone (Nutricia).Mateus Mistieri Simabukuro declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"92"}}